Centricity Research - Roswell - HyperCore - PPDS

Columbus, Georgia 31904-8946

0 studies enrolling now · 4 studies all time

What they study most

COVID-19, Respiratory Syncytial Virus

Studies at this site

• A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age — Completed
• Moderna Vaccine mRNA-1345 Observational Respiratory Syncytial Virus (RSV) Study — Completed
• PBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19 — Stopped early
• A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345 in Healthy Adults and in Children Who Are Respiratory Syncytial Virus (RSV)-Seropositive — Completed